A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo

A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochemical Pharmacology - Volume 88, Issue 2, 15 March 2014, Pages 158-168

Nataly Tarasenko, Suzanne M. Cutts, Don R. Phillips, Gili Berkovitch-Luria, Elinor Bardugo-Nissim, Michal Weitman, Abraham Nudelman, Ada Rephaeli,